|
|
Stefan HOLZHAUSER Tel.: +43 (0)512 9003-70745 |
Biographical sketch
Medical and Pharmaceutical Biotechnology studies at the IMC University of Applied Sciences Krems, Austria (Bachelor and Master) – PhD in Cancer in Genetics at the School of Medicine, Cardiff University, UK – cancer – Targeted therapy - 3D cell culture – Pathogens
Current Position
Postdoctoral Researcher (Universitätsassistent)
Education
| 2018 | PhD in Cancer and Genetics (Head and Neck Cancer, HPV, Cell line development), Cardiff University, School of Medicine, Division of Cancer and Gentecis, US |
| 2014 | Master in Medical and Pharmaceutical Biotechnology, IMC University of Applied Sciences,Krems, Austria |
| 2012 | Bachelor in Medical and Pharmaceutical Biotechnology, IMC University of Applied Sciences,Krems Austria |
| 2008 | Matura, BRG/BORG St.Pölten, Austria |
Career History
| since 2024 | Post-Doc, Institute of Hygiene and Medical Microbiology, AG_Assoz.-Prof. PD Mag. Dr.rer.nat. Wilfried Posch, Innsbruck, Austria |
| 2021-2024 | Post-Doc, Department of Oncolgy-Pathology, Karolinska Institutet, Sweden (Barncancerfonden Post-Doc position) |
| 2018-2021 | Post-Doc, Department of Oncolgy-Pathology, Karolinska Institutet, Sweden (sponsored by Radiumhemmets Forskningsfonder) |
| 2014-2018 | Doctoral Candidate (PhD) at Cardiff University, UK |
| 2013-2014 | Visiting Scientist (7 months Master internship) at the Karolinska Institutet, Department of Oncology-Pathology, Stockholm, Sweden |
| 2011-2012 | Visiting Scientist (7 months Bachelor internship) at the Garvan Institute of Medical Research. Pancreatic Cancer research group: Prof. Andrew Biankin, Sydney, Australia |
Publications
 |
Projects
| 2022-2024 | Strategies for new and optimal combinations of targeted therapy in childhood cancer (Barnancancerfonden, Stockholm, Sweden) |
Awards
| 2-year funded Postdoc position by Barncancerfonden (TJ2022-0067) at the Karolinska Institutet, Department of Oncology-Pathology, Stockholm, Sweden |
Teaching
